These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 8394992
1. Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system. Aharony D, Little J, Powell S, Hopkins B, Bundell KR, McPheat WL, Gordon RD, Hassall G, Hockney R, Griffin R. Mol Pharmacol; 1993 Aug; 44(2):356-63. PubMed ID: 8394992 [Abstract] [Full Text] [Related]
2. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA. Aharony D, Little J, Thomas C, Powell S, Berry D, Graham A. Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285 [Abstract] [Full Text] [Related]
3. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery. Aharony D, Little J, Thomas C, Powell S, Downey-Jones M, Graham A. J Recept Res; 1994 Dec; 14(6-8):399-421. PubMed ID: 7877137 [Abstract] [Full Text] [Related]
4. Pharmacologic characterization of the novel ligand [4,5-3H-Leu9]neurokinin-A binding to NK-2 receptors on hamster urinary bladder membranes. Aharony D, Conner GE, Woodhouse DP. Neuropeptides; 1992 Oct; 23(2):121-30. PubMed ID: 1333574 [Abstract] [Full Text] [Related]
5. Expression of rat NK-2 (neurokinin A) receptor in E. coli. Grisshammer R, Little J, Aharony D. Recept Channels; 1994 Oct; 2(4):295-302. PubMed ID: 7719707 [Abstract] [Full Text] [Related]
6. Binding of the novel ligand [4,5-3H-Leu10]substance P to high-affinity NK-1 receptors on guinea pig lung membranes: modulation by GTP analogs and sulfhydryl modifying agents. Aharony D, Catanese CA, Woodhouse DP. J Pharmacol Exp Ther; 1991 Oct; 259(1):146-55. PubMed ID: 1717678 [Abstract] [Full Text] [Related]
7. Characterization of the [125I]-neurokinin A binding site in the circular muscle of human colon. Warner FJ, Comis A, Miller RC, Burcher E. Br J Pharmacol; 1999 Jul; 127(5):1105-10. PubMed ID: 10455255 [Abstract] [Full Text] [Related]
9. Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888. Miyayasu K, Mak JC, Nishikawa M, Barnes PJ. Mol Pharmacol; 1993 Sep; 44(3):539-44. PubMed ID: 7690449 [Abstract] [Full Text] [Related]
10. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor. Goso C, Astolfi M, Parlani M, Manzini S. Eur J Pharmacol; 1995 Dec 27; 294(1):239-45. PubMed ID: 8788437 [Abstract] [Full Text] [Related]
11. Characterization of NK-1 receptors in guinea pig and rat brain membranes with NK-1 peptides and a non-peptide antagonist. Tousignant C, Chrétien L, Guillemette G, Regoli D. Brain Res; 1992 Nov 20; 596(1-2):243-50. PubMed ID: 1281744 [Abstract] [Full Text] [Related]
12. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists. Blaney FE, Raveglia LF, Artico M, Cavagnera S, Dartois C, Farina C, Grugni M, Gagliardi S, Luttmann MA, Martinelli M, Nadler GM, Parini C, Petrillo P, Sarau HM, Scheideler MA, Hay DW, Giardina GA. J Med Chem; 2001 May 24; 44(11):1675-89. PubMed ID: 11356103 [Abstract] [Full Text] [Related]
13. Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412). Giardina GA, Raveglia LF, Grugni M, Sarau HM, Farina C, Medhurst AD, Graziani D, Schmidt DB, Rigolio R, Luttmann M, Cavagnera S, Foley JJ, Vecchietti V, Hay DW. J Med Chem; 1999 Mar 25; 42(6):1053-65. PubMed ID: 10090788 [Abstract] [Full Text] [Related]
14. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs. Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM. J Pharmacol Exp Ther; 2002 Jan 25; 300(1):314-23. PubMed ID: 11752131 [Abstract] [Full Text] [Related]
16. Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor. Renzetti AR, Catalioto RM, Criscuoli M, Cucchi P, Ferrer C, Giolitti A, Guelfi M, Rotondaro L, Warner FJ, Maggi CA. J Pharmacol Exp Ther; 1999 Aug 25; 290(2):487-95. PubMed ID: 10411554 [Abstract] [Full Text] [Related]
19. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle. Bergström L, Beaujouan JC, Torrens Y, Saffroy M, Glowinski J, Lavielle S, Chassaing G, Marquet A, D'Orleans-Juste P, Dion S. Mol Pharmacol; 1987 Dec 25; 32(6):764-71. PubMed ID: 2826990 [Abstract] [Full Text] [Related]